Eastman Chemical (EMN)
NYSE: EMN
· Real-Time Price · USD
66.40
-0.15 (-0.23%)
At close: Aug 14, 2025, 3:59 PM
66.30
-0.15%
Pre-market: Aug 15, 2025, 04:31 AM EDT
Eastman Chemical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.29B | 9.36B | 9.38B | 9.34B | 10.92B | 10.89B | 10.99B | 11.16B | 9.82B | 10.28B | 10.58B | 10.9B | 10.91B | 10.78B | 10.48B | 9.97B | 9.37B | 8.64B |
Cost of Revenue | 7.05B | 7.01B | 7.07B | 7.13B | 8.84B | 8.84B | 8.95B | 9.19B | 7.79B | 8.16B | 8.44B | 8.58B | 8.47B | 8.33B | 7.98B | 7.5B | 7.06B | 6.64B |
Gross Profit | 2.23B | 2.35B | 2.31B | 2.2B | 2.08B | 2.05B | 2.05B | 1.97B | 2.03B | 2.12B | 2.14B | 2.32B | 2.44B | 2.45B | 2.5B | 2.47B | 2.31B | 2B |
Operating Income | 1.34B | 1.43B | 1.39B | 1.22B | 1.12B | 1.07B | 1.06B | 1.01B | 1.07B | 1.22B | 1.28B | 1.71B | 1.77B | 1.72B | 1.74B | 1.46B | 1.35B | 1.09B |
Interest Income | 15M | 16M | 16M | 14M | 12M | 11M | 10M | 11M | 11M | 8M | 6M | 4M | 3M | 3M | 3M | 3M | 4M | 4M |
Pretax Income | 999M | 1.12B | 1.08B | 1.21B | 1.13B | 1.11B | 1.09B | 690M | 772M | 884M | 977M | 1.48B | 1.52B | 1.03B | 1.08B | 578M | 447M | 553M |
Net Income | 832M | 922M | 905M | 885M | 883M | 925M | 894M | 586M | 709M | 693M | 794M | 1.17B | 1.22B | 818M | 857M | 511M | 321M | 494M |
Selling & General & Admin | 630M | 655M | 664M | 745M | 722M | 727M | 727M | 708M | 721M | 721M | 726M | 762M | 790M | 807M | 795M | 761M | 725M | 678M |
Research & Development | 265M | 258M | 250M | 241M | 236M | 236M | 239M | 246M | 254M | 261M | 264M | 267M | 265M | 261M | 254M | 244M | 234M | 223M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 895M | 913M | 914M | 986M | 958M | 963M | 966M | 954M | 975M | 982M | 990M | 1.03B | 1.05B | 1.07B | 1.05B | 1B | 959M | 901M |
Interest Expense | 218M | 216M | 216M | 214M | 220M | 223M | 225M | 222M | 208M | 196M | 188M | 186M | 191M | 197M | 201M | 204M | 208M | 212M |
Selling & Marketing Expenses | -9M | -5M | n/a | 9M | -35M | -36M | -38M | -38M | 6M | 3M | n/a | n/a | n/a | n/a | n/a | 14M | 14M | 14M |
Cost & Expenses | 7.95B | 7.93B | 7.98B | 8.15B | 9.83B | 9.83B | 9.94B | 10.14B | 8.76B | 9.14B | 9.43B | 9.61B | 9.53B | 9.4B | 9.03B | 8.51B | 8.02B | 7.55B |
Income Tax Expense | 164M | 191M | 170M | 318M | 239M | 180M | 191M | 103M | 63M | 190M | 181M | 304M | 291M | 204M | 215M | 57M | 115M | 47M |
Shares Outstanding (Basic) | 115M | 116.7M | 116.7M | 116.4M | 117.3M | 117.4M | 118M | 118.5M | 118.8M | 118.9M | 119.5M | 121M | 124.8M | 129M | 132.5M | 135.3M | 135.9M | 136.1M |
Shares Outstanding (Diluted) | 116.2M | 117.9M | 117.9M | 117.8M | 118.6M | 118.2M | 118.7M | 119M | 119.6M | 119.7M | 120.5M | 122.3M | 126.4M | 130.7M | 134.6M | 137M | 135.9M | 137.6M |
EPS (Basic) | 7.20 | 7.94 | 7.76 | 7.54 | 7.49 | 7.81 | 7.54 | 4.93 | 5.92 | 5.69 | 6.38 | 9.21 | 9.32 | 6.20 | 6.39 | 3.77 | 2.36 | 3.63 |
EPS (Diluted) | 7.12 | 7.86 | 7.68 | 7.47 | 7.43 | 7.76 | 7.49 | 4.90 | 5.87 | 5.63 | 6.31 | 9.10 | 9.21 | 6.11 | 6.30 | 3.72 | 2.33 | 3.60 |
EBITDA | 1.72B | 1.84B | 1.8B | 1.92B | 1.84B | 1.82B | 1.83B | 1.51B | 1.57B | 1.72B | 1.76B | 2.19B | 2.3B | 1.79B | 1.87B | 1.4B | 1.23B | 1.48B |
EBIT | 1.22B | 1.33B | 1.29B | 1.42B | 1.35B | 1.34B | 1.32B | 920M | 984M | 1.08B | 1.17B | 1.67B | 1.71B | 1.74B | 1.8B | 1.3B | 1.17B | 771M |
Depreciation & Amortization | 509M | 508M | 509M | 498M | 491M | 484M | 498M | 497M | 494M | 497M | 477M | 482M | 492M | 510M | 538M | 561M | 583M | 584M |